Time's Up...So, by now FDA will have responded to ONCY's Type C Meeting questions. Unlikely that they have exceeded the 75 day goal date.
So what does the absence of an announcement from ONCY portend..? Well, if they were trying to get agreement on a biomarker (from FDA) to be used as a surrogate end-point, then it means Notable's spiel about Accelerated Approval is just talk.. it WON'T happen..
And how strange that Matt had a relapse just in time not to have to face the music... Oh btw, get well soon Matt.
So... we've lost our Business Development lead, and now the CEO (Kirk Crook looks set to remain), but since we change CMO's every few years, I wonder if even Professor Heineken will be next to make a move...
so, the ball is in your court now Mr Pisano... please do something, just anything with it...
hmmmm.. no news is bad news eh, until it is...